Tumor Treating Fields (TTFields) therapy vs physicians' choice standard-of-care treatment in patients with recurrent glioblastoma: a post-approval registry study (EF-19).

Zhu, Jay-Jiguang; Goldlust, Samuel A; Kleinberg, Lawrence R; Honnorat, Jérôme; Oberheim Bush, Nancy Ann; Ram, Zvi

Zhu, Jay-Jiguang; Goldlust, Samuel A; Kleinberg, Lawrence R; Honnorat, Jérôme; Oberheim Bush, Nancy Ann; Ram, Zvi.

Affiliation

Zhu JJ; University of Texas Health Science Center in Houston (UTHealth)/Memorial Hermann Hospital at Texas Medical Center, 6400 Fannin St., Suite 2800, Houston, TX, 77030, USA. jay.jiguang.zhu@uth.tmc.edu.
Goldlust SA; John Theurer Cancer Center, Hackensack, NJ, USA.
Kleinberg LR; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Honnorat J; Department of Neuro-Oncology, Hôpital Neurologique, Hospices Civils de Lyon, SynatAc Team, MELIS Institute, INSERM U1314/CNRS UMR5284, Université Claude Bernard Lyon 1, Université de Lyon, Lyon, France.
Oberheim Bush NA; Department of Neuro-Oncology, East Group Hospital, Hospices Civils de Lyon, Lyon Cedex, France.
Ram Z; Department of Neurological Surgery and Neurology, University of California, San Francisco, CA, USA.

Discov Oncol ; 13(1): 105, 2022 Oct 14.

Article in En | MEDLINE | ID: mdl-36239858

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Guideline Language: En Journal: Discov Oncol Year: 2022 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google